Disclosures: Dr. Yeh is an investigator at the Harvard Clinical Research Institute and has served as a consultant for the Kaiser Permanente Division of Research. Dr. White is an investigator for the Carotid Stenting Boston Scientific Surveillance Program (CABANA) trial from Boston Scientific Corp. Dr. Rosenfield reports receiving research grants from Abbott Vascular, Bard Peripheral Vascular, Medtronic/Invatec, and Atrium; receiving consulting/advisory board fees from Abbott Vascular, Boston Scientific Corp, Complete Conference Management, Harvard Clinical Research Institute, Contego, Micell, and Becker Ventures; having equity in Lumen Biomedical, Medical Stimulation Corp, Angioguard (Cordis), and Micell; and serving on the board of directors for VIVA Physicians (501C3). Dr. Jaff reports that he is a noncompensated advisor to Abbott Vascular, Cordis Corporation, Covidien Vascular, Medtronic Vascular; received advisory board fees from Becker Venture Services, Bluegrass Vascular Therapies, Hansen Biomedical, Trivascular, and Vortex Medical; has equity interests in Access Closure, Embolitech, Hotspur, Icon Interventional, I.C. Sciences, Janacare, Northwind Medical, PQ Bypass, Primacea, Sadra Medical, Trireme, Vascular Therapies; and is a member of the board of directors of VIVA Physicians, a 501(c)3 education and research not-for-profit organization. Dr. Parikh receives research grants from Medtronic and CR Bard and is a consultant to Medtronic and Boston Scientific. Dr. Giri, Dr. Hawkins, Mr. Kennedy, Dr. I. Weinberg, and Dr. M. Weinberg have no relevant disclosures.
Jay Giri and Robert W. Yeh contributed equally to this work.